Trial Profile
Mirvaso Gel and Dysport for Erythema and Flushing of Rosacea
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Brimonidine (Primary)
- Indications Erythema; Flushing; Rosacea
- Focus Therapeutic Use
- 02 May 2018 New trial record